Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Combined Administration of Erythropoietin in Umbilical Cord Blood Therapy for Stroke Patients

NCT04013646 is registered in ClinicalTrials.gov with Bundang CHA Hospital as lead sponsor.

NCT NCT04013646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04013646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Combined Administration of Erythropoietin in Umbilical Cord Blood Therapy for Stroke Patients
Lead sponsor
Bundang CHA Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 2, 2019
Completion date
November 2, 2021
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythropoietin, safety, stroke, treatment outcome, umbilical cord blood